TNFRSF8 and anaplastic large cell lymphoma: Here we build on the ELISA approach to introduce a lateral flow assay (LFA) that can be delivered at point-of-care for detection of CD30 in BIA-ALCL effusions/seromas within 20 min by unspecialized personnel using less than 1 mL of fluid.